On April 9, Johnson & Johnson and Children’s National Health System announced a collaborative launch of JLABS @ Washington, D.C. Located at the new Children’s National Research and Innovation Campus. This facility will bring together broad stakeholders and expand Children’s National research programs in pediatric genomic and precision medicine.
“It’s clear that Washington, D.C. has the talent, ideas, and passion to support a robust healthcare industry, biotech sector, and tech scene, and we are proud to welcome Johnson & Johnson Innovation as they join Children’s National,” said Washington, D.C. Mayor Muriel Bowser.
The launch will also boost the collaboration between J&J Innovation - JLABS and the Biomedical Advanced Research Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services. The partnership will focus on the advancement of medical countermeasures against chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging infectious diseases.
“Collaboration is at the heart of our efforts to change the trajectory of health for humanity. We are proud to once again collaborate with Children’s National and BARDA, with the goal of speeding healthcare innovation in the greater Washington, D.C. metro area to the benefit of all,” said William N. Hait, MD, PhD, Global Head, Johnson & Johnson External Innovation, and Research!America Board Member.
In honor of the opening of JLABS @ Washington, D.C., JLABS launched the DC Children’s QuickFire Challenge. Innovators and entrepreneurs with the best ideas on the development and commercialization of pediatric-centered health care innovation will receive up to $150,000 in grant funding in addition to one year of residency at JLABS @ Washington, D.C., and mentoring from the Johnson & Johnson Family Corporation. Applications are open now and through February 7, 2020. Find more information about the application process here.